Breast cancer (BC) is a heterogeneous disease consisting of several different subtypes that, until recently, was classified according to the presence of estrogen receptor (ER), progesterone receptor (PR) and/or human epidermal growth factor receptor 2 (HER2) hormone receptors [1,2,3]. This evidence concerns the gene NR4A1 and breast cancer.